FOLLOW-UP OF ANTITUBERCULOUS TREATMENT

Tuberculosis is a first magnitude sanitary problem with several factor s that make difficult its eradication, among these are particularly im portant those derived from the antituberculous therapy: noncompliance and adverse reactions to the drugs used. We have developed a follow-up program for ambulatory patients with antituberculous therapy that inc ludes compliance control and systematical survey or possible adverse r eactions. We expose our results after its application to 39 patients w ith tuberculosis and 24 with tuberculous infection. The compliance lev el among patients with tuberculous disease was 100% and among those wh o were receiving chemoprophylaxis 75%, both values much higher than th ose found in the literature. We detected adverse reactions in 43.6% of the patients with tuberculous treatment and 37.5% of those receiving chemoprophylaxis with isoniazid. Setting up follow-up programs in anti tuberculous treatments notably helps to improve the compliance and the safety of treatment